Robert L. Ferrara, Director at Phio Pharmaceuticals Corp. (PHIO), bought 2,500 shares at $2.42 ($6K) on 2025-06-10, disclosed to the SEC on 2025-06-11.
Open-market purchase of $6k PHIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PHIO | BUY | 2022-12-05 | $2K | — | Filing → |
| PHIO | BUY | 2022-11-28 | $820 | — | Filing → |
| PHIO | BUY | 2021-03-03 | $2K | — | Filing → |